A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples